Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
Neurologic Events after Partial Exchange Transfusion for Priapism in Sickle Cell Disease
J Pediatr 120:882-885, Rackoff,W.R.,et al, 1992
Seizures Related to Blood Transfusion and Erythropoietin Treatment in Patients Undergoing Dialysis
BMJ 299:1258-1259, Brown,A.L.,et al, 1989
Neurological Manifestations in Three German Children with AIDS
Neuropediatrics 18:99-106, Biggemann,B.,et al, 1987
Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
West Nile Virus Among Blood Donors in the United States, 2003 and 2004
NEJM 353:451-459,516, Stramer,S.L.,et al, 2005
Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005
Tissue Distribution of Bovine Spongiform Encephalopathy Agent in Primates after Intravenous or Oral Infection
Lancet 363:422-428,411, Herzog,C.,et al, 2004
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004
Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients
NEJM 348:2196-2203, Iwamoto,M.,et al, 2003
Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Arch Neurol 58:2017-2021, Pegelow,C.H.,et al, 2001
Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998
Discontinuation of Long-Term Transfusion Therapy in Patients with Sickle Cell Disease & Stroke
J Pediatr 131:757-760, Rana,S.,et al, 1997
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Ann Int Med 117:933-946, Gessain,A.&Gout,O., 1992
High Risk of Recurrent Stroke after Discont of 5 to 12 Yrs of Transfusions in Sickle Cell Disease
J Pediatr 118:377-379, Wang,W.C.,et al, 1991
HTLV-I-Associated Myelopathy Associated with Blood Transfusion in the US:Epidemiologic & Molecular Evidence
Neurol 41:192-197, Kaplan,J.E.,et al, 1991
HTLV-I-Associated Myelopathy
NEJM 323:552, Engel,W.K.,et al, 1990
Nationwide Survey of HTLV-I-Associated Myelopathy in Japan:Ass with Blood Transufsion
Ann Neurol 28:50-56, Osame,M.,et al, 1990
Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990
Detection of Human T-Cell Leukemia/Lymphoma Virus Type I in a Transfusion Recipient with Chronic Myelopathy
Neurol 39:841-844, Saxton,E.H.,et al, 1989
Transient Polyradiculoneuropathy Following a Febrile Transfusion Reaction
Arch Neurol 39:597-598, Ritch,P.S.,et al, 1982
Precautions in Familial Transmissible Dementia
Arch Neurol 35:697-698, Cook,R.,et al, 1978